Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Sunday, May 3, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Biotech
CEM Corporation & AmbioPharm Form U.S. Partnership for GMP Peptide Production
Life Sciences Times
-
September 14, 2021
0
Medtech
Emergn Study Highlights Importance of Human-Machine Relationship to Realize Potential of Intelligent Automation
Life Sciences Times
-
September 14, 2021
0
Venture Capital
Prospection Secures $45 million to Accelerate Growth of its Powerful Healthcare Insights Technology
Life Sciences Times
-
September 14, 2021
0
Pharma
Rocket Pharmaceuticals Presents Clinical Data from RP-A501 Trial in Danon Disease
Life Sciences Times
-
September 14, 2021
0
People on the Move
ReForm Biologics Names Neal Muni, MD, MSPH, Executive Vice President and Chief Operating Officer
Life Sciences Times
-
September 14, 2021
0
Venture Capital
Nectero Medical Completes $19.5 Million Series C Financing
Life Sciences Times
-
September 13, 2021
0
Medtech
Masimo Launches Single-patient-use rainbow® SuperSensor™
Life Sciences Times
-
September 13, 2021
0
Medtech
Results Published from RHINTRAC Randomized Controlled Trial Demonstrate Safety and Efficacy of Aerin Medical’s RhinAer
Life Sciences Times
-
September 13, 2021
0
Medtech
Sensome Begins Human Trial for Its AI-Powered Stroke Guidewire
Life Sciences Times
-
September 13, 2021
0
Public Health
Recent Fluvoxamine COVID benefits discovered using Cytel-designed platform trial
Life Sciences Times
-
September 13, 2021
0
1
...
735
736
737
...
831
Page 736 of 831
Most Popular
Radiology Partners Appoints Former Maryland Gov. Larry Hogan to Board
May 1, 2026
SK Capital Completes Sale of Noramco Group Businesses to Siegfried
May 1, 2026
GoodRx Expands Access to Oral Ozempic for Type 2 Diabetes Patients
May 1, 2026
Seaport Therapeutics Prices Upsized IPO at $18 Per Share
May 1, 2026
Load more
Recent Comments
Recent Comments